Rebuttal from authors re: Joaquim Bellmunt. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail? Eur Urol 2009;55:1310-2

Eur Urol. 2009 Jun;55(6):1313-4. doi: 10.1016/j.eururo.2008.09.066. Epub 2008 Oct 9.

Authors

Antoine Italiano¹, Karim Fizazi

Affiliation

¹ Department of Medical Oncology, Institut Bergonié, Bordeaux, France. [email protected]

PMID: 18849106
DOI: 10.1016/j.eururo.2008.09.066

No abstract available

Publication types

Comment
Editorial

MeSH terms

Aged
Aged, 80 and over
Aging / drug effects
Antineoplastic Agents, Hormonal / administration & dosage*
Antineoplastic Agents, Hormonal / adverse effects
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Clinical Trials as Topic
Dose-Response Relationship, Drug
Frail Elderly
Geriatric Assessment
Humans
Male
Patient Selection
Prognosis
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / mortality
Prostatic Neoplasms / pathology
Risk Assessment
Survival Analysis
Treatment Outcome

Substances

Antineoplastic Agents, Hormonal